{"id": "c0000000", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "A Comprehensive Review of Gestational Diabetes Mellitus: Impacts on Maternal Health, Fetal Development, Childhood Outcomes, and Long-Term Treatment Strategies Vaishnavi S Nakshine 1,✉, Sangita D Jogdand 2 Editors: Alexander Muacevic, John R Adler Author information Article notes Copyright and License information PMCID: PMC10663705 PMID: 38021940 Abstract This review article conducts a comprehensive analysis of gestational diabetes mellitus (GDM) and its ramifications for both maternal health and the well-being of their offspring.", "nodes": ["condition:gestational diabetes mellitus", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.13}
{"id": "c0000001", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM is a significant pregnancy complication in which women who have never had diabetes acquire chronic hyperglycemia during their gestational period.", "nodes": ["condition:hyperglycemia", "condition:gdm", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000002", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In most cases, hyperglycemia is caused by impaired glucose tolerance caused by pancreatic beta cell dysfunction in the background of chronic insulin resistance.", "nodes": ["tissue:beta cell", "condition:hyperglycemia", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000003", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Being overweight or obese, having an older mother age, and having a family history of any type of diabetes are all risk factors for developing GDM.", "nodes": ["condition:gdm", "condition:overweight", "risk_factor:family history", "risk_factor:age"], "edge_types": ["INCREASES_RISK"], "edge_evidence": {"INCREASES_RISK": 3}, "confidence": 0.63}
{"id": "c0000004", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM consequences include a higher risk of maternal cardiovascular disease (CVD) and type 2 diabetes, as well as macrosomia and delivery difficulties in the newborn.", "nodes": ["tissue:liver", "condition:gdm", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_fetal:macrosomia", "outcome_longterm:type 2 diabetes", "outcome_longterm:cardiovascular disease"], "edge_types": ["POSTPARTUM_T2DM_RISK"], "edge_evidence": {"POSTPARTUM_T2DM_RISK": 3}, "confidence": 0.72}
{"id": "c0000005", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "There is also a longer-term risk of obesity, type 2 diabetes, and cardiovascular disease in the infant.", "nodes": ["condition:type 2 diabetes", "condition:obesity", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes", "outcome_longterm:cardiovascular disease"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000006", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Premature birth, hypoglycemia at birth, and shoulder dystocia are also a few of the fetal problems that can result from GDM.", "nodes": ["condition:hypoglycemia", "condition:gdm", "outcome_fetal:shoulder dystocia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000007", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Unfortunately, there is no widely acknowledged treatment or preventative strategy for GDM at the moment, except lifestyle modification (diet and exercise) and, on occasion, insulin therapy, which is only of limited value due to the insulin resistance that is commonly present.", "nodes": ["condition:gdm", "condition:insulin resistance", "intervention:insulin", "intervention:diet", "intervention:exercise", "intervention:lifestyle", "drug:insulin"], "edge_types": ["TREATED_BY"], "edge_evidence": {"TREATED_BY": 3}, "confidence": 0.72}
{"id": "c0000008", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Although new oral medications for diabetes management, such as glyburide and metformin, show potential, there are ongoing worries regarding their safety over an extended period for both the mother and the child.", "nodes": ["intervention:metformin", "intervention:glyburide", "drug:metformin", "drug:glyburide", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000009", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "By identifying gaps in the research, it calls for further investigations and a multidisciplinary approach, ultimately aiming to enhance the management and care for women with GDM, which would impact these affected individuals indubitably.", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000010", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Although one can develop GDM at any instance during the entire course of pregnancy, it is typically seen between weeks 24 and 28 of pregnancy.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000011", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Additionally, the prevalence of GDM is growing globally due to an increase in maternal weight gain, maternal age, and inactivity [3].", "nodes": ["condition:gdm", "risk_factor:maternal age", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000012", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The etiology of GDM is explained by the maternal pancreas' inability to adjust to the increased insulin demand throughout gestation.", "nodes": ["tissue:pancreas", "condition:gdm", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000013", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "During pregnancy, the body becomes less responsive to insulin, which leads to an increased production of insulin by pancreatic beta cells [4].", "nodes": ["tissue:beta cell", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000014", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Insulin, which is secreted by these beta cells, plays a vital role in promoting the uptake of glucose by peripheral tissues, reducing the synthesis of glucose in the liver, and controlling the release of lipids from adipose tissue.", "nodes": ["tissue:liver", "tissue:beta cell", "tissue:adipose", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000015", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "However, if regular levels of insulin fail to achieve the desired response from insulin receptors, insulin resistance can develop.", "nodes": ["condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000016", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Consequently, beta cells must produce more insulin than usual to maintain normal maternal blood glucose levels [1].", "nodes": ["tissue:beta cell", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000017", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This insulin resistance is a natural part of a healthy pregnancy and is induced by placental hormones to ensure the fetus receives the necessary nourishment for proper growth and development.", "nodes": ["hormone:placental hormones", "tissue:placenta", "tissue:fetus", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000018", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Maternal beta cells respond by increasing their number, insulin production, and release to sustain glucose balance despite insulin resistance [5].", "nodes": ["tissue:beta cell", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000019", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "However, when maternal beta cells cannot adapt to the metabolic changes associated with pregnancy, gestational diabetes mellitus (GDM) results in hyperglycemia.", "nodes": ["tissue:beta cell", "condition:gestational diabetes mellitus", "condition:hyperglycemia", "condition:gdm", "guideline_org:ada"], "edge_types": ["FAILURE_LEADS_TO_GDM"], "edge_evidence": {"FAILURE_LEADS_TO_GDM": 3}, "confidence": 0.66}
{"id": "c0000020", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM is essential to detect and treat during pregnancy due to the harmful impact it has on both the mother and the fetus, in both the short and long runs.", "nodes": ["tissue:fetus", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000021", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Gestational diabetes can cause short-term pregnancy complications such as high blood pressure, the necessity for a cesarean section (C-section), pre-eclampsia, and difficulty during childbirth [6].", "nodes": ["outcome_maternal:c-section", "outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000022", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In the long run, it may reappear in subsequent pregnancies, increasing the mother's risk of developing type 2 diabetes later in life [7,8].", "nodes": ["condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000023", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Many recent researches have focused on treating GDM with GM-targeting techniques.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000024", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Several prior research have looked at the influence of probiotics on the progression of GDM, but results have been ambiguous.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000025", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM treatment tries to reduce the hazards for both the mother and the infant by controlling excessive blood sugar levels.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000026", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Mothers must learn about the illness in order to achieve the best possible blood sugar control in GDM patients.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000027", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The primary therapies for GDM involve adopting lifestyle changes such as modifying your diet, exercising regularly, and maintaining a healthy weight.", "nodes": ["condition:gdm", "intervention:diet", "intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000028", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM medication comprises glucose-lowering drugs, metformin, glibenclamide, and insulin [9].", "nodes": ["condition:gdm", "intervention:insulin", "intervention:metformin", "intervention:glibenclamide", "drug:metformin", "drug:insulin", "drug:glibenclamide"], "edge_types": [], "edge_evidence": {}, "confidence": 0.36}
{"id": "c0000029", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insulin sensitivity [10].", "nodes": ["condition:gdm", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000030", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Review Search methodology We undertook a comprehensive search through PubMed and CENTRAL in June 2023 using keywords such as \"gestational diabetes mellitus\" and \"type 2 diabetes mellitus\" ((gestational diabetes mellitus [title/abstract]) OR (GDM [title/abstract])) OR (macrosomia [title/abstract]) OR (\"gestational diabetes mellitus\" [MeSH terms]) AND ((\"type 2 diabetes mellitus\" [title/abstract]) OR (T2DM [title/abstract])) OR (\"type 2 diabetes mellitus\" [MeSH terms]).", "nodes": ["condition:gestational diabetes mellitus", "condition:t2dm", "condition:gdm", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_fetal:macrosomia", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.28}
{"id": "c0000031", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 1 Open in a new tab PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses Effects on the mother GDM subsequently causes several short- and long-term complications with regard to maternal health.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000032", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Along with the challenges of a typical pregnancy, GDM may contribute to depression in prenatal [11].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000033", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In many instances, the baby must be delivered surgically due to the increased risk of issues in subsequent pregnancies, such as premature birth and hypertension [12].", "nodes": ["tissue:liver", "condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000034", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Women who have been diagnosed with GDM are significantly more likely to develop diabetes mellitus later in life.", "nodes": ["condition:gdm", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000035", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Nearly 10% of women with gestational diabetes mellitus are diagnosed with diabetes mellitus shortly post giving birth [13].", "nodes": ["condition:gestational diabetes mellitus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000036", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "nodes": ["condition:gdm", "outcome_maternal:postpartum diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000037", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Regardless, the risk of prenatal problems brought on by GDM is substantially lower than the likelihood of the mother developing diabetes mellitus post-GDM diagnosis.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000038", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Therefore, it is logical to assume that GDM is a type of prediabetes similar to glucose intolerance in non-pregnant people [15].", "nodes": ["condition:prediabetes", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000039", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Plenty of patients who have diabetes mellitus after GDM meet the pre-type 2 diabetes mellitus (T2DM) profile, as was previously discussed.", "nodes": ["condition:t2dm", "condition:gdm", "condition:type 2 diabetes", "guideline_org:who", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000040", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Studies on the regulation of glucose following GDM over time show declining beta cell remuneration for insulin resistance (chronic) that may also deteriorate as time passes [16].", "nodes": ["tissue:beta cell", "condition:gdm", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": ["BETA_CELL_LIMITATION", "PERSISTENT_INSULIN_RESISTANCE"], "edge_evidence": {"BETA_CELL_LIMITATION": 2, "PERSISTENT_INSULIN_RESISTANCE": 3}, "confidence": 0.94}
{"id": "c0000041", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Markers of rather severe decompensation, such as elevated glucose levels, noticeable insulin resistance, and impaired beta cell activity, are risk factors for the relatively quick onset of diabetes mellitus following childbirth.", "nodes": ["tissue:beta cell", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000042", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell deterioration at comparatively high rates, which leads to diabetes mellitus [18].", "nodes": ["hormone:adiponectin", "tissue:beta cell", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": ["BETA_CELL_LIMITATION"], "edge_evidence": {"BETA_CELL_LIMITATION": 2}, "confidence": 0.58}
{"id": "c0000043", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "These results imply that the metabolic consequences of obesity serve a key role in the degeneration of beta cells that result in diabetes mellitus.", "nodes": ["tissue:beta cell", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000044", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "As will be covered below, the most effective defense against the emergence of T2DM after GDM is the amelioration of the detrimental consequences of obesity induced by diet and exercise or by taking medications that improve the biological makeup and operation of adipose tissue [19].", "nodes": ["tissue:adipose", "condition:t2dm", "condition:gdm", "condition:obesity", "intervention:diet", "intervention:exercise"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000045", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cell function and addressing obesity to mitigate this risk effectively.", "nodes": ["tissue:beta cell", "condition:gdm", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000046", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Metabolic factors influencing post-GDM: the role of beta cell function and obesity management.", "nodes": ["tissue:beta cell", "condition:gdm", "condition:obesity", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000047", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 2 Open in a new tab GDM: gestational diabetes mellitus Image credits: Vaishnavi Nakshine Metabolic syndrome, which includes obesity and other associated diseases, serves as the foundation upon which T2DM develops.", "nodes": ["condition:gestational diabetes mellitus", "condition:metabolic syndrome", "condition:t2dm", "condition:gdm", "condition:obesity", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000048", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The probability of women with GDM displaying symptoms of metabolic syndrome is higher than it is for women without GDM [17].", "nodes": ["condition:metabolic syndrome", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000049", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "A greater frequency of cardiovascular risk factors and cardiovascular events is also linked to previous episodes of GDM [20].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000050", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Most mothers who have GDM are obese, and a sizable fraction of obese people also have GDM [21].", "nodes": ["condition:gdm", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000051", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "According to a meta-analysis, pregnant women who are overweight are 2.14 times more susceptible to be diagnosed with GDM than pregnant women average in weight, obese pregnant women are 3.56 times more likely to do so, and extremely obese pregnant women are 8.56 times more likely [22].", "nodes": ["condition:gdm", "condition:overweight", "guideline_org:who", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000052", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "There is a chance of a long labor process during which the fetus could get clung in the birth/vaginal canal, an instrumental delivery may be required (using forceps or a vacuum), or even an unanticipated or emergency cesarean section might be required.", "nodes": ["tissue:liver", "tissue:fetus", "outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000053", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Heavy bleeding and postpartum hemorrhage may occur as a result of the uterus' muscle failing to contract appropriately.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000054", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000055", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In addition, if the woman has already undergone a cesarean section, there is an increased probability of tearing of the uterus along the surgical scar tissue from the prior procedure.", "nodes": ["outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000056", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Fetal complications and effects Premature Birth Preterm delivery is possible as a result of inducing labor early (earlier than 39 weeks and/or early rupturing of the membrane).", "nodes": ["tissue:liver", "threshold_or_timing:39 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.31}
{"id": "c0000057", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Preterm delivery has a prevalence of roughly 10.6% worldwide when combined with several other problematic factors such as obesity and hypertension during pregnancy [25].", "nodes": ["tissue:liver", "condition:hypertension", "condition:obesity", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000058", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Hypoglycemia at Birth In addition to having a negative impact on mothers, GDM also harms the fetus.", "nodes": ["tissue:fetus", "condition:hypoglycemia", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000059", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The growing fetus can only produce a small amount of glucose; hence, it gets the majority of its glucose from the mother's blood.", "nodes": ["tissue:fetus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000060", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "While maternal insulin does not pass the placenta, maternal glucose does.", "nodes": ["tissue:placenta", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000061", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The modified Pedersen's theory, therefore, states that regardless of glucose stimulation, greater fetal insulin production results from extra glucose transported across the placenta in high and uncontrolled maternal glucose levels [22].", "nodes": ["tissue:placenta", "intervention:insulin", "drug:insulin"], "edge_types": ["CROSSES_PLACENTA"], "edge_evidence": {"CROSSES_PLACENTA": 2}, "confidence": 0.52}
{"id": "c0000062", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This is corroborated by the placental expression of glucose transport proteins (GLUTs) being found to be higher in pregnancies with insulin-dependent diabetes mellitus [26].", "nodes": ["tissue:placenta", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000063", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Additionally, insulin is known to have the ability to activate mTOR, a powerful controller of cell proliferation.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000064", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The placenta's system A and system L amino acid transporters boost cell division and the supply of essential nutrients to the fetus as a result of elevated maternal insulin, which also causes a surge in placental mTOR activity [27].", "nodes": ["tissue:placenta", "tissue:fetus", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000065", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Maternal hyperglycemia and hyperinsulinemia can result in alterations in the fetus that are comparable to those found in GDM due to the aforementioned causes, which can result in neonatal obesity [28].", "nodes": ["tissue:fetus", "condition:hyperglycemia", "condition:gdm", "condition:obesity", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000066", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "An increase in neonatal size at birth, also known as macrosomia, is the result of excessive nutrition storage.", "nodes": ["outcome_fetal:macrosomia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000067", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Macrosomic babies are born in 15%-45% of GDM pregnancies [22].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000068", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Additionally, GDM has been linked to a higher incidence of respiratory distress in newborns [1].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000069", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Shoulder Dystocia and Erb's Palsy Shoulder dystocia, particularly linked to birth trauma, is one of the most serious consequences of administering delivery through the vagina, specifically in macrosomic infants.", "nodes": ["tissue:liver", "outcome_fetal:shoulder dystocia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000070", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Newborns weighing 4,500 g or greater are six times more likely than others to experience birth trauma [23], and furthermore, if the birth weight is above 4,500 g, there is an almost 20-fold increased chance of brachial plexus damage [29].", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000071", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Congenital abnormalities can result from the growing fetus' organ damage caused by the elevated blood sugar levels of women with GDM [30].", "nodes": ["tissue:fetus", "condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000072", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Furthermore, it is not certain if GDM and fetal anomalies are related.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000073", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The data for GDM, however, is inconsistent [1].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000074", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Fetal Nutrition With the onset of GDM, changes in breast milk composition are seen too.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000075", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Numerous maternal variables, including term and preterm labor, maternal diet, metabolic problems, and diseases [31], have an impact on it.", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000076", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Due to the beneficial correlation between mammary gland growth during pregnancy and circulating levels of human placental lactogen, women having gestational diabetes during their pregnancy may have a delay at the beginning of breast milk [34].", "nodes": ["hormone:human placental lactogen", "hormone:placental lactogen", "tissue:placenta"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000077", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Interleukin (IL)-6, IL-15, and interferon-γ levels were up, whereas IL-1ra and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels were decreased.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000078", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Neonatal complications Neonatal complications can include delivery trauma, such as shoulder dystocia and a brachial plexus wound, as well as potential hypoxia, hypoglycemia, kernicterus, and jaundice.", "nodes": ["tissue:liver", "condition:hypoglycemia", "outcome_fetal:shoulder dystocia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000079", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Neonates with macrosomia have an elevated oxygen demand, which leads to elevated erythropoiesis and, ultimately, polycythemia [36].", "nodes": ["outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000080", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Childhood and adulthood complications It is generally known that GDM and hyperglycemia in children are related.", "nodes": ["condition:hyperglycemia", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000081", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The research of the Pima Indians in the USA was the first concrete proof that a mother's hyperglycemia may cause her offspring to develop an adult illness.", "nodes": ["condition:hyperglycemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000082", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Indeed, children who have diabetic mothers experience an increased risk of obesity, hypertension, and dyslipidemia in later adulthood [37].", "nodes": ["condition:hypertension", "condition:obesity", "guideline_org:who", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000083", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In 10 different countries, researchers from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study discovered a direct link between maternal hyperglycemia during pregnancy and a rise in hyperglycemia and insulin resistance in children as they grew older [38].", "nodes": ["condition:hyperglycemia", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000084", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Additionally, compared to offspring of mothers with normal blood sugar levels, GDM progeny had a higher homeostatic model assessment of insulin resistance (HOMA-IR), waist measurement, body mass index (BMI), and triglyceride levels [39].", "nodes": ["condition:gdm", "condition:insulin resistance", "intervention:insulin", "drug:insulin", "risk_factor:bmi"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000085", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "With about 20% of offspring resulting from GDM having type 2 diabetes and prediabetes by 22, it is plausible that the development of being resistant to insulin raises the chance of the child getting the disease [40].", "nodes": ["condition:prediabetes", "condition:gdm", "condition:type 2 diabetes", "intervention:insulin", "drug:insulin", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.36}
{"id": "c0000086", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Along with an increased risk of illnesses including cardiovascular conditions and resistance to insulin, the greater incidence of obesity in children of women with GDM is also linked to an increased risk of other diseases [40].", "nodes": ["condition:gdm", "condition:obesity", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000087", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In addition to hyperglycemia and BMI, children delivered to GDM mothers were shown to have considerably greater cardiovascular risk and adiposity.", "nodes": ["tissue:liver", "condition:hyperglycemia", "condition:gdm", "risk_factor:bmi"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000088", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM kids are more likely to experience cardiac arrhythmias and require hospitalization for cardiovascular diseases (CVDs) as a result of increased cardiovascular risk [39].", "nodes": ["condition:gdm", "outcome_longterm:cardiovascular disease"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000089", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In addition, GDM offspring are 29% more likely to suffer early-onset cardiovascular conditions such as cardiac failure, high blood pressure, deep vein thrombosis, and pulmonary embolism [41].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000090", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Numerous studies also indicate that the long-duration impacts of in utero GDM subjection often do not manifest themselves until adolescence, another period that is particularly vulnerable to the development of obesity [23].", "nodes": ["condition:gdm", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000091", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Treatment A comprehensive strategy is needed to handle an individual with GDM as best as possible.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000092", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This entails educating patients on managing pregnancy weight gain, dietary adjustments, nutritional monitoring, and regulating one's blood sugar levels.", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000093", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "With enough exercise, dietary changes, and lifestyle adjustments, up to 70%-85% of those with gestational diabetes are curable [42].", "nodes": ["intervention:diet", "intervention:exercise", "intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000094", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Insulin and oral hypoglycemics are some of them.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000095", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 3 provides a concise overview of the management strategies to be employed for controlling GDM.", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000096", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 3 Open in a new tab GDM: gestational diabetes mellitus Image credits: Vaishnavi Nakshine Blood Glucose Monitoring The majority of organizations advise daily at-home self-glucose monitoring.", "nodes": ["condition:gestational diabetes mellitus", "condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000097", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Presently, daily self-monitoring of postprandial and fasting blood glucose levels is encouraged.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000098", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The American Diabetes Association (ADA) advises that the target blood sugar levels be 95 mg/dL for fasting and 140 mg/dL or 120 mg/dL for one to two hours, respectively, following a meal.", "nodes": ["guideline_org:ada", "threshold_or_timing:95 mg/dL", "threshold_or_timing:140 mg/dL", "threshold_or_timing:120 mg/dL"], "edge_types": ["MONITORING_TARGETS"], "edge_evidence": {"MONITORING_TARGETS": 3}, "confidence": 0.73}
{"id": "c0000099", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Screening the levels of hemoglobin A1C is not as helpful for evaluating glucose control in GDM [43].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000100", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Dietary Modifications Some of the dietary strategies mentioned in the literature include the DASH diet (dietary techniques to treat hypertension), calorie-restricted diets, low-glycemic index diets, low-carbohydrate diets, low-unsaturated fat diets, high-fiber diets, and soy-based diets.", "nodes": ["condition:hypertension", "intervention:diet", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000101", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The emphasis of nutritional advice should be on a balanced diet with reasonable portion sizes, healthy fats, complex carbs, and 20% protein [44].", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000102", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Physical Exercise Even in pregnant women with GDM, physical activity and regular exercise have been promoted and are encouraged.", "nodes": ["condition:gdm", "intervention:exercise", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000103", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The benefits of moderate exercise during pregnancy include a lower risk of gestational diabetes, a lower potential of larger-than-normal newborns, and a lower risk of high blood pressure problems, preterm birth, and fetal growth restriction [45].", "nodes": ["intervention:exercise", "outcome_fetal:preterm birth"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000104", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Additionally, pregnancy-related lifestyle modifications affect the period of postpartum, reducing the chance of postpartum depression [46].", "nodes": ["intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000105", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Pharmacotherapy for GDM Management In about 15%-30% of GDM patients, blood glucose management is insufficient despite suggested dietary and lifestyle changes, necessitating the use of medication [43].", "nodes": ["condition:gdm", "intervention:diet", "intervention:lifestyle", "risk_factor:age"], "edge_types": ["TREATED_BY"], "edge_evidence": {"TREATED_BY": 3}, "confidence": 0.63}
{"id": "c0000106", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Usually, if hyperglycemia still exists throughout the course of the day after 10-14 days of nutritional and daily living changes, medication courses should be taken into account.", "nodes": ["condition:hyperglycemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000107", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Insulin and oral-route medications are administered for patients with gestational diabetes mellitus in order to control hyperglycemia [47].", "nodes": ["condition:gestational diabetes mellitus", "condition:hyperglycemia", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000108", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Insulin provides the most secure outline during pregnancy.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000109", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The oral medications that have been researched include metformin and sulfonylureas such as glyburide.", "nodes": ["intervention:metformin", "intervention:glyburide", "drug:metformin", "drug:glyburide"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000110", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Large molecules such as insulin cannot pass through the placenta.", "nodes": ["tissue:placenta", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000111", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Metformin and glyburide have been demonstrated to have the capacity to pass the placental barrier and reach the fetus [48].", "nodes": ["tissue:placenta", "tissue:fetus", "intervention:metformin", "intervention:glyburide", "drug:metformin", "drug:glyburide"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000112", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 4 depicts functions as an illustrative guide outlining the diagnostic and therapeutic procedures for gestational diabetes mellitus.", "nodes": ["condition:gestational diabetes mellitus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000113", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Figure 4 Open in a new tab GDM: gestational diabetes mellitus Image credits: Vaishnavi Nakshine Table 1 presents an analysis of the traits and features of the articles included in the review.", "nodes": ["condition:gestational diabetes mellitus", "condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000114", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "GDM: gestational diabetes mellitus, rPL: rat placental lactogen, GCT: glucose challenge test, T2DM: type 2 diabetes mellitus, CVD: cardiovascular disease, LGA: large for gestational age, IDM: infants of diabetic mothers, NIDM: infants of mothers without diabetes Authors Year Findings Alejandro et al.", "nodes": ["hormone:placental lactogen", "tissue:placenta", "condition:gestational diabetes mellitus", "condition:t2dm", "condition:gdm", "condition:type 2 diabetes", "test:glucose challenge test", "test:gct", "outcome_maternal:type 2 diabetes", "outcome_fetal:large for gestational age", "outcome_fetal:lga", "outcome_longterm:type 2 diabetes", "outcome_longterm:cardiovascular disease", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.45}
{"id": "c0000115", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[1] 2020 This review emphasizes the seriousness of GDM and the problems involved with its care, such as recognizing and dealing with risk factors, accurate diagnosis, and treatment of the condition to avoid associated consequences.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000116", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[2] 2016 GDM is becoming more common in most populations, and it is extremely certain that GDM is contributing to the global diabetes epidemic.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000117", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[3] 2022 The one-step approach resulted in two to three times the number of women being diagnosed with GDM as the two-step approach.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000118", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[4] 2010 The findings suggest that maternal glycemia during pregnancy may have a long-term effect on offspring obesity risk.", "nodes": ["condition:obesity", "outcome_longterm:offspring obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000119", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Furthermore, they provide evidence that rPL-I may be the essential hormone signal that initiates the fundamental adaptive alterations in islet function associated with pregnancy.", "nodes": ["guideline_org:ada"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000120", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[7] 2012 GDM is associated with a significantly elevated risk of unfavorable perinatal outcomes, with insulin-treated GDM having a greater probability of most outcomes than non-insulin-treated GDM.", "nodes": ["condition:gdm", "intervention:insulin", "drug:insulin"], "edge_types": ["TREATED_BY"], "edge_evidence": {"TREATED_BY": 3}, "confidence": 0.6}
{"id": "c0000121", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "American Diabetes Association [9] 2004 The risk of GDM should be assessed during the first prenatal checkup.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000122", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "A history of depression may also be a warning sign for the onset of GDM.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000123", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[12] 2009 Women who tested positive for GCT had a higher risk of having an unfavorable pregnancy outcome.", "nodes": ["test:gct", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000124", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The GCT's role and threshold must be reconsidered.", "nodes": ["test:gct"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000125", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[13] 2012 Even among the vast majority of women who do not have autoimmunity or monogenic diabetes, there is significant variation in GDM.", "nodes": ["condition:gdm", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000126", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[15] 2005 The research found that the prevalence of GDM is rising in a multiethnic community that has been universally screened.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000127", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The growing incidence of GDM shows that the vicious cycle of diabetes in pregnancy initially identified among Pima Indians may be spreading to other ethnic communities in the United States.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000128", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[16] 2010 Women who are the most behind at diagnosis and/or deteriorate the fastest are particularly likely to get type 2 diabetes within 12 years after the index pregnancy.", "nodes": ["condition:type 2 diabetes", "guideline_org:who", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000129", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[17] 2010 GDM and mild glucose intolerance during pregnancy significantly indicate an elevated risk of metabolic syndrome at three months postpartum, lending credence to the idea that women with prenatal dysglycemia may have an underlying latent metabolic syndrome.", "nodes": ["condition:metabolic syndrome", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000130", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[18] 2010 Weight gain is the main predictor related to deteriorating beta cell compensation for insulin resistance in Hispanic women at high risk of type 2 diabetes, according to these findings.", "nodes": ["tissue:beta cell", "condition:type 2 diabetes", "condition:insulin resistance", "intervention:insulin", "drug:insulin", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": ["BETA_CELL_LIMITATION"], "edge_evidence": {"BETA_CELL_LIMITATION": 2}, "confidence": 0.64}
{"id": "c0000131", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This effect could be mediated by at least two mechanisms: changes in adipokine levels and increased insulin resistance.", "nodes": ["condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000132", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[19] 2007 The findings in a multiethnic US sample imply that hyperglycemia during pregnancy is linked to an increased risk of juvenile obesity.", "nodes": ["condition:hyperglycemia", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000133", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[20] 2009 Women with diabetes during pregnancy and women who had an oral glucose tolerance test but did not have gestational diabetes had an increased risk of cardiovascular disease after a 12.3-year median follow-up when compared with women who were not given a test for oral glucose tolerance.", "nodes": ["test:oral glucose tolerance test", "guideline_org:who", "outcome_longterm:cardiovascular disease"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000134", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[21] 2012 Medical therapies that prevent the progression of T2DM, such as metformin, might turn out to be our major line of defense against CVD in women with GDM.", "nodes": ["condition:t2dm", "condition:gdm", "intervention:metformin", "drug:metformin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000135", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[22] 2004 This study examines research that investigated the impact of GDM and fetal macrosomia on delivery outcomes, as well as macrosomia-related problems, and provides an assessment of mother and fetal health.", "nodes": ["tissue:liver", "condition:gdm", "outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000136", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[24] 1986 Aside from women who have already delivered a macrosomic child, cesarean delivery of the macrosomic fetus is strongly advised.", "nodes": ["tissue:liver", "tissue:fetus", "guideline_org:who", "outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000137", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[25] 1986 Obesity and pregestational diabetes are both linked to a higher risk of LGA delivery.", "nodes": ["tissue:liver", "condition:obesity", "outcome_fetal:lga"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000138", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[26] 2020 This review looks at how the localization, function, and evolution of placental glucose transport systems vary during fetal development, as well as the transport and metabolic abnormalities seen in prenatal diseases.", "nodes": ["tissue:placenta"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000139", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[27] 2016 Obese mice with activated placental insulin/IGF-I/mTOR and leptin signaling pathways boost placental amino acid transport and contribute to higher fetal growth.", "nodes": ["hormone:leptin", "tissue:placenta", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000140", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[28] 2017 IDM patients had much more obesity than NIDM patients.", "nodes": ["condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000141", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[29] 1986 Findings show that there is a considerable risk of major birth damage related to instrumental midpelvic delivery.", "nodes": ["tissue:liver", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000142", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[31] 2012 Breastfeeding and the usage of human milk provide distinct nutritional and non-nutritional benefits to the infant and mother, which improves infant, child, and adult fitness and child milestones.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000143", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[32] 2020 Diabetes along with obesity, in both human and animal models, can disrupt the physiological production and biological action of placental lactogen.", "nodes": ["hormone:placental lactogen", "tissue:placenta", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000144", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[33] 2021 Maternal diabetes has a major impact on the structure and function of the fetal heart and fetal placental circulation.", "nodes": ["tissue:placenta"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000145", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[34] 2021 Over 80% of women who delivered prematurely and were producing milk for their newborn had a delayed initiation of lactation, defined as one or more lactogenesis II markers in their milk that were more than 3 SD higher than the mean of full-term women on day 5 postpartum.", "nodes": ["tissue:liver", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000146", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[36] 2004 Metformin and glibenclamide drugs may be effective and secure alternatives to insulin for the management of gestational diabetes, with metformin being preferred.", "nodes": ["intervention:insulin", "intervention:metformin", "intervention:glibenclamide", "drug:metformin", "drug:insulin", "drug:glibenclamide", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.36}
{"id": "c0000147", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[37] 1983 Obesity develops in childhood and early adulthood as a result of the perinatal environment of diabetic women's infants.", "nodes": ["condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000148", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[39] 2010 The fact that overweight risk is mostly connected with maternal obesity shows that genetic predisposition plays a role in childhood growth among these children.", "nodes": ["condition:obesity", "condition:overweight"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000149", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[41] 2019 Offspring of diabetic mothers, particularly those with a history of cardiovascular diseases or diabetic complications, had higher rates of early-onset heart diseases from childhood to early adulthood.", "nodes": ["outcome_longterm:cardiovascular disease"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000150", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[44] 2020 Regular examinations along with testing, at least once per 1-3 years, are indicated for early detection of type 2 diabetes and to prevent long-term complications of diabetes mellitus.", "nodes": ["condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000151", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[45] 2017 Regular exercise throughout pregnancy enhances general wellness and aids in the maintenance of a suitable gestational and fetal weight increase.", "nodes": ["intervention:exercise"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000152", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[46] 2017 Women who received lifestyle treatments were comparatively less inclined to experience postnatal depression and were more likely to meet their postpartum weight goals.", "nodes": ["guideline_org:who", "intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000153", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[47] 2002 A randomized clinical trial of moderate gestational diabetes mellitus determines if early detection and treatment of the condition improve neonatal morbidity.", "nodes": ["condition:gestational diabetes mellitus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000154", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "[48] 2015 Aspart, glargine, and detemir are all safe alternatives for treating diabetes during pregnancy; in this research conducted, these insulin analogs did not increase difficulties for mothers or fetuses.", "nodes": ["tissue:fetus", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000155", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Open in a new tab Conclusions Global health continues to be seriously impacted by GDM, the most common metabolic condition during pregnancy.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000156", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This review shed light on the immediate and long-term consequences of GDM on pregnant women.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000157", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Short-term consequences encompass a higher likelihood of gestational hypertension, cesarean sections, and other perinatal complications.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension", "outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000158", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitoring and care for women who have experienced GDM.", "nodes": ["condition:gdm", "condition:type 2 diabetes", "guideline_org:who", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000159", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Furthermore, GDM's influence on offspring is a matter of critical concern.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000160", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This review underscores that children of GDM-affected mothers face a higher risk of developing conditions such as obesity, hypertension, and insulin resistance, which can persist into adulthood.", "nodes": ["condition:gdm", "condition:hypertension", "condition:insulin resistance", "condition:obesity", "intervention:insulin", "drug:insulin", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.36}
{"id": "c0000161", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Understanding these intergenerational health implications is vital for proactive prevention and management.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000162", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "To address GDM effectively, a multifaceted approach is required.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000163", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "This approach includes vigilant blood glucose monitoring, dietary modifications, regular physical activity, and, when necessary, pharmaceutical interventions.", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000164", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "The effective management of GDM relies on a collaborative effort between healthcare professionals and expectant mothers, emphasizing education and tailored care.", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000165", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "A clinical dietitian should provide dietary advice to all women with GDM, as dietary counseling is the cornerstone of GDM treatment.", "nodes": ["condition:gdm", "intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000166", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "While considerable progress has been made in GDM research and treatment, there are still gaps in knowledge and variances in clinical recommendations.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000167", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Moreover, a variety of therapy alternatives for GDM are discussed, although existing data do not support the effectiveness of these approaches over the long term.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000168", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "Future research must focus on a more comprehensive understanding of the long-term cardiometabolic risks that the offspring of GDM-affected mothers may face.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000169", "doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "text": "In addition, for the prevention and control of GDM, an integrated strategy combining population-wide preventive management, intensive health education, early detection, and multidisciplinary care programs should be strengthened, which could help reduce the risk of GDM and associated complications in the general population and high-risk individuals, improve maternal and neonatal pregnancy outcomes, and promote long-term health.", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": ["IMPROVES_OUTCOMES"], "edge_evidence": {"IMPROVES_OUTCOMES": 3}, "confidence": 0.57}
{"id": "c0000170", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Diabetes mellitus and pregnancy Fathi I Abourawi 1 Author information Article notes Copyright and License information PMCID: PMC3081498 PMID: 21526019 Abstract Diabetes mellitus is the most common medical complication of pregnancy and it carries a significant risk to the foetus and the mother.", "nodes": ["tissue:foetus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000171", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Gestational diabetes mellitus (GDM) which manifests for the first time during pregnancy is common and on the increase, its proper management will reduce the risk of neonatal macrosomia and hypoglycaemia.", "nodes": ["condition:gestational diabetes mellitus", "condition:gdm", "condition:hypoglycaemia", "outcome_fetal:macrosomia", "risk_factor:age"], "edge_types": ["IMPROVES_OUTCOMES"], "edge_evidence": {"IMPROVES_OUTCOMES": 3}, "confidence": 0.66}
{"id": "c0000172", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Post-partum evaluation of glucose tolerance and appropriate counselling in women with GDM may help decrease the high risk of subsequent type 2 diabetes in the longterm.", "nodes": ["condition:gdm", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000173", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "This article will briefly review the changes in the carbohydrate metabolism that characterise normal pregnancy and will focus on a practical approach to the care of patients with pre-existing diabetes as well as GDM.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000174", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "nodes": ["tissue:foetus", "condition:gestational diabetes mellitus", "condition:gdm", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": ["VARIES_WITH_BACKGROUND_T2DM"], "edge_evidence": {"VARIES_WITH_BACKGROUND_T2DM": 3}, "confidence": 0.61}
{"id": "c0000175", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Despite major advances in clinical management, we are still facing a higher incidence of malformations and perinatal morbidity compared to the non-diabetic population.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000176", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Over the past 30 years, great strides have been made in improving the outcomes of women with type 1 diabetes who become pregnant.", "nodes": ["condition:type 1 diabetes", "guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000177", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "However, during the past decade, type 2 diabetes in pregnancy has emerged and is certain to become a prominent concern.[3] The St Vincent Declaration, which has been adopted by most European countries, calls for (an outcome in diabetic pregnancy approximating the non-diabetic women).[4] Unfortunately, pregnancy target has been achieved only in a few centres of excellence in Scandinavia and by the small intensive pre-conception control arm of the nine-year US Diabetes Control and Complications Trial.[5] Normal Glucose Regulation during Pregnancy: Metabolic changes occur in normal pregnancy in response to the increase in nutrient needs of the foetus and the mother.", "nodes": ["tissue:foetus", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.19}
{"id": "c0000178", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "There are two main changes which are seen during pregnancy, progressive insulin resistance that begins near mid-pregnancy and progresses through the third trimester to the level that approximates the insulin resistance seen in individuals with type 2 diabetes mellitus.", "nodes": ["condition:type 2 diabetes", "condition:insulin resistance", "intervention:insulin", "drug:insulin", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000179", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The insulin resistance appears to result from a combination of increased maternal adiposity and the placental secretion of hormones (progesterone, cortisol, placental lactogen, prolactin and growth hormone).", "nodes": ["hormone:cortisol", "hormone:growth hormone", "hormone:progesterone", "hormone:prolactin", "hormone:placental lactogen", "tissue:placenta", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.42}
{"id": "c0000180", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The fact that insulin resistance rapidly abates following delivery suggests that the major contributors to this state of resistance are placental hormones.", "nodes": ["hormone:placental hormones", "tissue:liver", "tissue:placenta", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000181", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The second change is the compensatory increase in insulin secretion by the pancreatic beta-cells to overcome the insulin resistance of pregnancy.", "nodes": ["tissue:pancreatic beta-cells", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000182", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "If there is maternal defect in insulin secretion and in glucose utilisation, then GDM will occur as the diabetogenic hormones rise to their peak levels.", "nodes": ["condition:gdm", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000183", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Risks to the Foetus & the Neonate (Tables 1 & 2): if the mother has hyperglycaemia, the foetus will be exposed to either sustained hyperglycaemia or intermittent pulses of hyperglycaemia; both situations prematurely stimulate foetal insulin secretion.", "nodes": ["tissue:foetus", "condition:hyperglycaemia", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000184", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Foetal complications in diabetic pregnancy Congenital anomalies: cardio-vascular central nervous system, skeletal (sacral agenesis), and genito-urinary Excessive foetal growth (macrosomia) Foetal growth retardation (in diabetic pregnancy complicated by nephropathy) Open in a new tab Table 2.", "nodes": ["outcome_fetal:macrosomia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000185", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Neonatal complications in diabetic pregnancy Traumatic delivery Pulmonary surfactant deficiency Hypoglycaemia Polycythaemia Hypocalcaemia Hypomagnesaemia Hyperbilirubinaemia Open in a new tab Foetal hyperinsulinaemia may cause increased foetal body fat (macrosomia) resulting in difficult delivery.", "nodes": ["tissue:liver", "condition:hypoglycaemia", "intervention:insulin", "drug:insulin", "outcome_fetal:macrosomia"], "edge_types": ["STIMULATES_INSULIN"], "edge_evidence": {"STIMULATES_INSULIN": 3}, "confidence": 0.66}
{"id": "c0000186", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The foetus may also have decreased potassium level caused by elevated insulin and glucose levels, and may therefore have cardiac arrhythmia.", "nodes": ["tissue:foetus", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000187", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Foetal organogenesis is completed by seven weeks post-conception and there is an increased prevalence of congenital anomalies and spontaneous abortions in diabetic women with poor glycaemic control during this period.[6] Because a woman may not even know she is pregnant at this time, it is imperative that pre-pregnancy counselling and planning occur in women of child-bearing age who have diabetes.", "nodes": ["guideline_org:who", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.13}
{"id": "c0000188", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "It seems that post-prandial glucose levels are the most important determining factor on the subsequent risk of neonatal macrosomia.", "nodes": ["outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000189", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Pregnancy in patients with diabetes is associated with a six-fold increase in perinatal mortality and a twofold increase in the rate of major congenital malformations and an eight fold increase in preterm delivery compared to the general population.[7–9] There is also an increase in neonatal hypoglycaemia which may cause permanent neurologic damage, hyperbilirubinaemia, respiratory distress and stillbirth.", "nodes": ["tissue:liver", "condition:hypoglycaemia", "outcome_fetal:stillbirth", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000190", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The associated increase of congenital anomalies for the foetus and spontaneous abortion in women with poor glycaemic control appears to be related to maternal glycaemic control rather than to the mode of anti-diabetic therapy during early pregnancy.", "nodes": ["tissue:foetus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000191", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Studies from many centres have shown that the higher the levels of glycosylated haemoglobin [HbA1c] in early pregnancy, the greater the incidence of anomalies and the higher the perinatal mortality.", "nodes": ["test:hba1c"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000192", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "[7–9] Risks to the mother (Table 3): Maternal diabetes complications are frequent in women with both type 1 and type 2 diabetes.", "nodes": ["condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000193", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Maternal complications in diabetic pregnancy Diabetic keto-acidosis Hypoglycaemia Visual deterioration/retinopathy Deterioration of nephropathy Vomiting (gastric neuropathy) Miscarriages Pre-eclampsia Polyhydramnios Premature delivery Open in a new tab Pre-eclampsia occurs in both type 1 and type 2 diabetes mellitus and is high as it affects approximately 20% of cases.", "nodes": ["tissue:liver", "condition:hypoglycaemia", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000194", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "[10] Other complications including polyhydramnios and worsening of chronic hypertension are not uncommon.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000195", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Management of Pregnancy in Women with Pre-existing Diabetes: Pre-pregnancy planning (Table 4) is essential to achieve a healthy baby and avoid maternal morbidity such as adverse pregnancy outcomes and progression of chronic diabetes complications.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000196", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Clinical trials of pre-conception care to achieve stringent blood glucose control in the pre-conception period and during the first trimester of pregnancy have demonstrated striking reductions in rates of malformation compared with infants of diabetic women who did not participate in pre-conception care.[11] Unfortunately, unplanned pregnancies occur in about two thirds of women with diabetes, precluding adequate pre-conception care and leading to persistent excess of malformations in their infants.", "nodes": ["guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.1}
{"id": "c0000197", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "To minimize the occurrence of these devastating malformations, standard care for all women with diabetes and of childbearing age should include.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000198", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Pre-pregnancy assessment Glycaemic control/appropriate medication Weight and diet Blood pressure/appropriate medication Review of diabetes complications: Retinopathy, nephropathy, autonomic neuropathy Coronary artery disease Smoking Rubella status Folic acid supplementation Open in a new tab Contraception for diabetic women: All forms of contraception carry some risk and every woman must be considered individually.", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000199", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The combined oral contraceptive pill is effective if taken reliably, however, the first generation, high dose oestrogen pills should be avoided as they may increase insulin requirement and increase the risk of vascular disease.", "nodes": ["hormone:estrogen", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000200", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The second and third generation pills have a much lower dose of oestrogen and can probably be used safely in the majority of women with diabetes.", "nodes": ["hormone:estrogen"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000201", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The progesterone-only pill is reliable if taken regularly but omission may be more likely to result in pregnancy than with the combined pill.", "nodes": ["hormone:progesterone"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000202", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Intra-uterine contraceptive devices have the advantage of the lack of detrimental metabolic effect and the need for compliance; however, its failure rate is high.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000203", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Optimise glycaemic control: In preparation for pregnancy, oral hypoglycaemic agents should be discontinued and insulin started if needed, statins and ACE-inhibitors should also be discontinued.", "nodes": ["intervention:insulin", "drug:insulin", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000204", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Hypertension should be controlled with safer drugs like Methyldopa, Nifedipine or Labetalol.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000205", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Regular self-monitoring should be encouraged to optimise control.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000206", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Glycaemic control should be optimised with the aim of pre-prandial blood glucose < 5.5 mmol/l (<95mg/dl) and HbA1c < 7%.", "nodes": ["test:hba1c", "threshold_or_timing:5.5 mmol/l", "threshold_or_timing:95mg/dl"], "edge_types": [], "edge_evidence": {}, "confidence": 0.34}
{"id": "c0000207", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Diabetes ante-natal care: this should be provided in a special clinic and the team caring for pregnant women should ideally include a Diabetes Nurse Specialist, Dietician, Diabetologist and an Obstetrician.", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000208", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued throughout pregnancy, fasting blood glucose should be kept < 5.5 mmol/l (<95mg/dl), post-prandial glucose < 7.8 mmol/l (<140 mg/dl) and HbA1c < 7%.", "nodes": ["test:hba1c", "threshold_or_timing:5.5 mmol/l", "threshold_or_timing:95mg/dl", "threshold_or_timing:7.8 mmol/l", "threshold_or_timing:140 mg/dl"], "edge_types": ["MONITORING_TARGETS"], "edge_evidence": {"MONITORING_TARGETS": 2}, "confidence": 0.68}
{"id": "c0000209", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Tighter glycaemic control may lead to an increase in episodes of severe hypoglycaemia and worsening of hypoglycaemia unawareness.", "nodes": ["condition:hypoglycaemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000210", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The patient should be aware of subtle signs of hypoglycaemia, and the patient's family should be taught the proper treatment of severe hypoglycaemia (i.e.", "nodes": ["condition:hypoglycaemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000211", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Glucose monitoring: Home blood glucose monitoring is an essential part of maintaining euglycaemic state and its goal is to detect glucose concentration to allow fine-tuning of insulin adjustment.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000212", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Pre-prandial glucose level < 5.5 mmol/l (<95mg/dl), and postprandial level glucose <7.8 mmol/ l (<140mg/dl).", "nodes": ["threshold_or_timing:5.5 mmol/l", "threshold_or_timing:95mg/dl", "threshold_or_timing:140mg/dl"], "edge_types": ["MONITORING_TARGETS"], "edge_evidence": {"MONITORING_TARGETS": 2}, "confidence": 0.62}
{"id": "c0000213", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Post-prandial glucose levels have been shown to correlate more with macrosomia than do fasting levels.", "nodes": ["outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000214", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Diabetes in early pregnancy studies found that third trimester post-prandial glucose levels were the strongest predictors of percentile birth weight.[12] Dietary advice: The goal of diet in pregnancy is to provide adequate nutrition for the mother and the foetus, provide sufficient calories for appropriate maternal weight gain, maintain normal glycaemia and avoid ketosis.", "nodes": ["tissue:foetus", "intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000215", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Monitoring with a pre-breakfast ketone measurement is recommended for patients who are on a hypo-caloric or carbohydrate restricted diet.", "nodes": ["guideline_org:who", "intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000216", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Insulin therapy: Insulin regimes should be individualised but in type 1 patients multiple injection/basal bolus regime of human insulin is preferable and in type 2, twice-daily injections may be appropriate.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": ["TREATED_BY"], "edge_evidence": {"TREATED_BY": 3}, "confidence": 0.57}
{"id": "c0000217", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The aim is to achieve blood glucose as near normal as possible without excessive risk of hypoglycaemia.", "nodes": ["condition:hypoglycaemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000218", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Hypoglycaemia: hypoglycaemia is common in pregnancy, particularly in the first trimester.", "nodes": ["condition:hypoglycaemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000219", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Education of patients and their families in the recognition and management of hypoglycaemia is vital.", "nodes": ["condition:hypoglycaemia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000220", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Ketoacidosis: Ketoacidosis is a preventable condition but potentially lethal to the foetus at any stage of pregnancy.", "nodes": ["tissue:foetus", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000221", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Women with microalbuminuria may experience transient worsening during pregnancy; however, those with established nephropathy with overt proteinuria are at increased risk of pre-eclampsia and intra-uterine growth retardation and premature delivery.", "nodes": ["tissue:liver"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000222", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "ACE-inhibitors for treatment of microalbuminuria should be discontinued in women who are attempting to become pregnant.", "nodes": ["guideline_org:who"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000223", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Hypertension: Hypertension is a frequent concomitant of diabetes.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000224", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Patients with type 1 diabetes frequently develop hypertension in association with diabetic nephropathy, as manifested by the presence of overt proteinuria.", "nodes": ["condition:hypertension", "condition:type 1 diabetes", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000225", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Patients with type 2 diabetes more commonly have hypertension as a concomitant disease.", "nodes": ["condition:type 2 diabetes", "condition:hypertension", "outcome_maternal:hypertension", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000226", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "In addition, pregnancy induced hypertension is a potential problem for women with diabetes.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000227", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Hypertension contributes to worsening of diabetic nephropathy and retinopathy in pregnancy.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000228", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "ACE-inhibitors, beta-blockers and diuretics should be avoided in women contemplating pregnancy if they are being used for hypertension.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000229", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Autonomic neuropathy particularly manifested by gastroparesis, hypoglycaemia unawareness, or orthostatic hypertension may complicate the management of diabetes in pregnancy.", "nodes": ["condition:hypoglycaemia", "condition:hypertension", "outcome_maternal:hypertension", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000230", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Cardiovascular disease: Untreated coronary artery disease is associated with a high mortality rate during pregnancy and women with significant coronary artery disease should be advised against pregnancy.", "nodes": ["outcome_longterm:cardiovascular disease"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000231", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Foetal monitoring: The major risks for the foetus of a diabetic woman are congenital malformations, intra-uterine death, usually after 30 weeks and macrosomia, which may result in significant problems in labour for both mother and baby.", "nodes": ["tissue:foetus", "outcome_fetal:macrosomia", "threshold_or_timing:30 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.34}
{"id": "c0000232", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Ultrasound scanning must be available for assessing gestational age, examining for congenital abnormalities and monitoring foetal growth and liquor volume.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000233", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "All diabetic patients should be counselled about the possibility of a neural tube defect and offered serum alphafetoprotein blood test between 15 and 19 weeks gestation.", "nodes": ["threshold_or_timing:19 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.28}
{"id": "c0000234", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "A detailed ultrasound scan at between 20 and 22 weeks for careful assessment of foetal anatomy is mandatory.", "nodes": ["threshold_or_timing:22 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.28}
{"id": "c0000235", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Ultrasound assessment should be carried out at each visit from 26 weeks.", "nodes": ["threshold_or_timing:26 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.28}
{"id": "c0000236", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The programme of surveillance must be modified if there are additional recognised risk factors, such as hypertension or renal disease.", "nodes": ["condition:hypertension", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000237", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Timing of delivery: Uncomplicated case with no evidence of foetal compromise, spontaneous delivery at term is standard practice.", "nodes": ["tissue:liver"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000238", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "When there are maternal complications of diabetes, complications of pregnancy, previous stillbirth or evidence of abnormal foetal growth, each case must be considered in its own merit with timely delivery in hospital.", "nodes": ["tissue:liver", "outcome_fetal:stillbirth"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000239", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Delivery by elective Caesarean section should be considered if the ultrasound estimated foetal weight is > 4kg.", "nodes": ["tissue:liver", "outcome_maternal:caesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000240", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "A previous Caesarean section in a diabetic woman will usually be managed by a repeat Caesarean section.", "nodes": ["outcome_maternal:caesarean", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000241", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "In the absence of these or other obstetric contra-indications a spontaneous vaginal delivery should be possible, with induction of labour as required.", "nodes": ["tissue:liver"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000242", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "If delivery is indicated before 36 weeks then administration of a steroid to the mother for 48 hours prior to delivery should be undertaken.", "nodes": ["tissue:liver", "threshold_or_timing:36 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.31}
{"id": "c0000243", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Steroids will upset glycaemic control and should only be given on an inpatient basis with careful monitoring of the glucose level and appropriate alteration of the insulin regime.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000244", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Management of labour and delivery: Glucose control during labour.", "nodes": ["tissue:liver", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000245", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "It is necessary to administer IV insulin and Dextrose to prevent ketoacidosis and to maintain the blood glucose as near normal as possible.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000246", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The insulin requirements after delivery should return to about the pre-pregnancy level.", "nodes": ["tissue:liver", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000247", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Labour and delivery of women with diabetes should be undertaken in units where there is neonatal care.", "nodes": ["tissue:liver"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000248", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "This would include hypoglycaemia, polycythaemia, respiratory distress syndrome, jaundice, hypocalcaemia and hypomagnesemia.", "nodes": ["condition:hypoglycaemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000249", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Insulin requirements fall dramatically at the time of delivery and insulin dose should be reduced to around the pre-pregnancy level.", "nodes": ["tissue:liver", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000250", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Breastfeeding also reduces insulin requirements and appropriate reduction should therefore be made once feeding is established.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000251", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "It is usually possible to stop insulin in women with GDM and in women with type 2 diabetes mellitus who do not intend to breastfeed.", "nodes": ["condition:gdm", "condition:type 2 diabetes", "guideline_org:who", "intervention:insulin", "drug:insulin", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.36}
{"id": "c0000252", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Gestational diabetes mellitus: GDM is defined as a glucose intolerance that begins or is first detected during pregnancy.", "nodes": ["condition:gestational diabetes mellitus", "condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000253", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Differences in screening programmes and diagnostic criteria make it difficult to compare frequencies of GDM among various populations.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000254", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Nevertheless, ethnicity has been proven to be an independent risk factor for GDM, which varies in prevalence in direct proportion to the prevalence of Type 2 diabetes in a given population or ethnic group.", "nodes": ["condition:gdm", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes", "risk_factor:ethnicity"], "edge_types": ["INCREASES_RISK", "VARIES_WITH_BACKGROUND_T2DM"], "edge_evidence": {"INCREASES_RISK": 3, "VARIES_WITH_BACKGROUND_T2DM": 3}, "confidence": 1.0}
{"id": "c0000255", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM develops when a woman is unable to secrete sufficient insulin to compensate for the increased insulin resistance during pregnancy.", "nodes": ["condition:gdm", "condition:insulin resistance", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000256", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "The foetus responds to hyperglycaemia by secreting large quantities of insulin.", "nodes": ["tissue:foetus", "condition:hyperglycaemia", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000257", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controversial, especially the threshold values for the diagnosis.", "nodes": ["condition:gdm", "condition:type 2 diabetes", "guideline_org:who", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000258", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "[15] Data from the Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study, correlating blood glucose levels with outcomes will hopefully lead to common agreement on the value for the diagnosis in future.[16] Screening methods for GDM vary from presence of maternal risk factors (table 5) to biochemical screening with 50gm OGTT (1hr blood glucose > 7.8 mmol/l (>140 mg/dl); screening based on maternal risk factors is more cost effective.[15] Table 5.", "nodes": ["condition:hyperglycaemia", "condition:gdm", "test:ogtt", "threshold_or_timing:7.8 mmol/l", "threshold_or_timing:140 mg/dl"], "edge_types": [], "edge_evidence": {}, "confidence": 0.32}
{"id": "c0000259", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Maternal risk factors for gestational diabetes Obesity Diabetes in first-degree relative Previous infant with macrosomia Previous diagnosis of GDM Age more than 35 years Polycystic ovary syndrome Multiparity Member of high risk population (e.g.", "nodes": ["condition:gdm", "condition:obesity", "outcome_fetal:macrosomia", "risk_factor:previous infant with macrosomia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000260", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Asian or African descent) Open in a new tab Several European centres support a glucose load of 75 gm for diagnosis performed between weeks 24 and 28 of gestation as recommended by the World Health Organization and the Diabetes Pregnancy Study Group of the European Association for the Study of Diabetes.[17] Management of GDM: Treatment of GDM can substantially reduce perinatal morbidity (table 6) from 4% to 1%.[18, 19] Women diagnosed with GDM should receive dietary advice and calorie intake should be reduced if overweight.", "nodes": ["condition:gdm", "condition:overweight", "intervention:diet", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.19}
{"id": "c0000261", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Perinatal complications of gestational diabetes mellitus Death: still birth and neonatal death Shoulder dystocia Bone fracture Nerve palsy Neonatal hypoglycemia Open in a new tab Such measures will achieve metabolic control in the majority of women.", "nodes": ["condition:hypoglycemia", "condition:gestational diabetes mellitus", "outcome_fetal:shoulder dystocia", "outcome_fetal:neonatal hypoglycemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000262", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insulin should be commenced with the aim of keeping pre-prandial blood glucose below 5.5 mmol/l (95 mg/dl), and two hour post-prandial below 7.8 mmol/l (140 mg/dl).", "nodes": ["intervention:insulin", "drug:insulin", "threshold_or_timing:5.5mmol/l", "threshold_or_timing:95 mg/dl", "threshold_or_timing:5.5 mmol/l", "threshold_or_timing:95 mg/dl", "threshold_or_timing:7.8 mmol/l", "threshold_or_timing:140 mg/dl"], "edge_types": [], "edge_evidence": {}, "confidence": 0.49}
{"id": "c0000263", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "There is limited data on the safety and efficacy of Glibenclamide or Metformin in GDM.", "nodes": ["condition:gdm", "intervention:metformin", "intervention:glibenclamide", "drug:metformin", "drug:glibenclamide"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000264", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria. (Table 7) Women with a history of GDM should be screened for GDM during any future pregnancy.", "nodes": ["tissue:liver", "condition:gdm", "test:oral glucose tolerance test", "guideline_org:who", "threshold_or_timing:6 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.4}
{"id": "c0000265", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "They should be advised to make life style changes to reduce their risk of subsequent type 2 diabetes mellitus.[14] For further reading, readers are advised to refer to the Report of the Expert Committee on the diagnosis and classification of Diabetes Mellitus.", "nodes": ["condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000266", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Reclassification of glucose tolerance status post-partum 75-g oral glucose tolerance test Fasting Plasma Glucose 2-hour OGTT Normal 6.1 mmol/1 [<110mg/dl] < 7.8mmol/l [140mg/dl] Impaired 5.6–6.9mmol/1 [100–125mg/dl] Impaired fasting glucose 7.8–11mmol/l [140–199mg/dl] Impaired glucose tolerance Diabetes >7mmol/l [126mg/dl] > 11.1mmol/l [200mg/dl] Open in a new tab Acknowledgement The author is grateful to Diane Willerton for typing the manuscript.", "nodes": ["test:ogtt", "test:oral glucose tolerance test", "test:fasting plasma glucose", "threshold_or_timing:110mg/dl", "threshold_or_timing:7.8mmol/l", "threshold_or_timing:140mg/dl", "threshold_or_timing:125mg/dl", "threshold_or_timing:199mg/dl", "threshold_or_timing:126mg/dl", "threshold_or_timing:11.1mmol/l", "threshold_or_timing:200mg/dl"], "edge_types": ["MONITORING_TARGETS"], "edge_evidence": {"MONITORING_TARGETS": 2}, "confidence": 0.75}
{"id": "c0000267", "doc": "Diabetes_mellitus_and_pregnancy.txt", "text": "Note For converting plasma glucose SI units to conventional units multiply by 18 (1 mmol/l = 18 mg/dl)", "nodes": ["threshold_or_timing:18 mg/dl"], "edge_types": [], "edge_evidence": {}, "confidence": 0.28}
{"id": "c0000268", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Management of Diabetes in Pregnancy: A Review of Clinical Guidelines and Practices Raniah A Albairmani 1, Basheer M Basheer 1, May M Macky 2, Tala Al Syouti 1, Haya AlZubaidy 3, Eyman Elfaki 1, Alweena Kidwai 1, Yousif M Basheer 4, Fatma Ahmed 4, Mona Salaheldin 5,✉ Editors: Alexander Muacevic, John R Adler Author information Article notes Copyright and License information PMCID: PMC11928751 PMID: 40125239 Abstract This literature review assesses clinical guidelines for pre-existing diabetes and gestational diabetes mellitus (GDM) in the areas of diagnosis, management, and maternal-fetal outcomes.", "nodes": ["condition:gestational diabetes mellitus", "condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.16}
{"id": "c0000269", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "A structured search was conducted across PubMed and Google Scholar, supplemented by targeted screening of guideline repositories from the American Diabetes Association (ADA), National Institute for Health and Care Excellence (NICE), and World Health Organization (WHO).", "nodes": ["guideline_org:who", "guideline_org:ada", "guideline_org:nice"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000270", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "A comparative analysis of guidelines from the ADA, NICE, and WHO was performed to evaluate prevalence, therapeutic approaches, and postpartum management.", "nodes": ["guideline_org:who", "guideline_org:ada", "guideline_org:nice", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000271", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Early diagnosis, stringent blood glucose control, and multidisciplinary care with the aim to avoid macrosomia, congenital abnormalities, and neonatal hypoglycemia guide the management guidelines.", "nodes": ["condition:hypoglycemia", "outcome_fetal:macrosomia", "outcome_fetal:neonatal hypoglycemia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000272", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Glycated hemoglobin (HbA1c) (<6.5%) optimization and supplementation with folic acid are critically required prior to conception in all women with previously diagnosed diabetes.", "nodes": ["test:hba1c"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000273", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Continuous glucose monitoring (CGM) and insulin pump therapy are valued but burdened by availability and access constraints.", "nodes": ["test:continuous glucose monitoring", "test:cgm", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000274", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "nodes": ["test:ogtt", "test:oral glucose tolerance test", "threshold_or_timing:4-12 weeks"], "edge_types": ["POSTPARTUM_OGTT"], "edge_evidence": {"POSTPARTUM_OGTT": 3}, "confidence": 0.7}
{"id": "c0000275", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Expansion of coverage by insurance for CGM and preconception care is important for providing equal access.", "nodes": ["test:cgm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000276", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Diabetes can be classified broadly into two categories: pre-gestational diabetes, which involves type 1 and type 2 diabetes diagnosed before pregnancy, and gestational diabetes mellitus (GDM), which emerges during pregnancy and corrects after delivery.", "nodes": ["tissue:liver", "condition:gestational diabetes mellitus", "condition:gdm", "condition:type 2 diabetes", "outcome_maternal:type 2 diabetes", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000277", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Global GDM prevalence is 2-10%, with low- and middle-income countries having a higher prevalence due to inadequate access to health care.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000278", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "GDM is present in 15-25% of pregnancies in the UAE, where it is driven by obesity and genetic susceptibility, while pre-existing diabetes is seen in 1-3% of pregnancies [1].", "nodes": ["condition:gdm", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000279", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The prevalence of GDM significantly varies depending on population and diagnostic criteria and has been estimated to affect between 2% and 10% of pregnancies worldwide [2].", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000280", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Maternal risks include preeclampsia, cesarean delivery, and worsening of pre-existing diabetes.", "nodes": ["tissue:liver", "condition:preeclampsia", "outcome_maternal:preeclampsia", "outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000281", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In contrast, fetal risks include macrosomia, birth defects, preterm birth, neonatal hypoglycemia, and long-term risks such as obesity and type 2 diabetes mellitus (T2DM) later in life [3].", "nodes": ["condition:hypoglycemia", "condition:t2dm", "condition:type 2 diabetes", "condition:obesity", "outcome_maternal:type 2 diabetes", "outcome_fetal:preterm birth", "outcome_fetal:macrosomia", "outcome_fetal:neonatal hypoglycemia", "outcome_longterm:type 2 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.42}
{"id": "c0000282", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "This review compares the guidelines on diabetes management in pregnancy such as preconception care, screening, and therapeutic interventions, emphasizing the need for early intervention and health equity.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000283", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "nodes": ["test:hba1c"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000284", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Also, the goal is to convert from teratogenic medication, such as angiotensin-converting enzyme (ACE) inhibitors, to insulin safely, attain the best possible control, and minimize risk while changing medication [3].", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000285", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It has been seen that women with a family history of diabetes, a history of GDM, or a history of having given birth to a macrosomic baby are at higher risk of developing GDM, and thus early intervention is critical [4].", "nodes": ["condition:gdm", "risk_factor:family history"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000286", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In addition, pre-existing diabetes in women is complicated by aggravated retinopathy, nephropathy, hypertension, and preeclampsia.", "nodes": ["condition:preeclampsia", "condition:hypertension", "outcome_maternal:preeclampsia", "outcome_maternal:hypertension"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000287", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "This must be incorporated into an individualized preconception care plan, as required for the patient, to optimize maternal and fetal well-being and reduce risks of pregnancy complications [6].", "nodes": [], "edge_types": ["IMPROVES_OUTCOMES"], "edge_evidence": {"IMPROVES_OUTCOMES": 3}, "confidence": 0.51}
{"id": "c0000288", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Screening for diabetes in early pregnancy The incidence of T2DM among women of childbearing age is rising.", "nodes": ["condition:t2dm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000289", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Since T2DM often presents without symptoms in its initial stages and women with significant hyperglycemia early in pregnancy face a higher risk of adverse outcomes, early detection and treatment of diabetes are paramount.", "nodes": ["condition:hyperglycemia", "condition:t2dm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000290", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "As a result, most international associations such as the International Association of Diabetes and Pregnancy Study Groups (IADPSG), the American Diabetes Association (ADA), and the World Health Organization (WHO) recommend therefore to screen for overt diabetes at the first antenatal visit using an FPG, HbA1c, or 75 g oral glucose tolerance test (OGTT) with the same cut-offs as for non-pregnant populations.", "nodes": ["test:hba1c", "test:fpg", "test:ogtt", "test:oral glucose tolerance test", "guideline_org:who", "guideline_org:ada", "guideline_org:iadpsg"], "edge_types": [], "edge_evidence": {}, "confidence": 0.28}
{"id": "c0000291", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "To confirm a diagnosis of overt diabetes, FPG and HbA1c measurements should ideally be repeated twice.", "nodes": ["test:hba1c", "test:fpg"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000292", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "While HbA1c is useful for screening diabetes, its lower sensitivity in pregnancy, due to erythrocyte turnover, limits its utility for GDM [8].", "nodes": ["condition:gdm", "test:hba1c"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000293", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Clinical guidelines of GDM: overview Clinical guidelines on the management of diabetes in pregnancy have been developed by several prestigious professional associations like ADA, the International Diabetes Federation (IDF), the National Institute for Health and Care Excellence (NICE), and WHO.", "nodes": ["condition:gdm", "guideline_org:who", "guideline_org:ada", "guideline_org:idf", "guideline_org:nice", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000294", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Specifically, their guidelines are developed to enhance maternal and fetal outcomes and ensure optimal management of diabetes throughout pregnancy.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000295", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Their guidelines also stress the need for a multidisciplinary team to manage diabetes in pregnant women, which may include obstetricians, endocrinologists, dietitians, and diabetes educators [9].", "nodes": ["intervention:diet", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000296", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "GDM is a common complication of pregnancy, and its usual method of diagnosis is screening for glucose intolerance.", "nodes": ["condition:gdm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000297", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The most widely used method is the OGTT.", "nodes": ["test:ogtt"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000298", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Both ADA 2023 and NICE 2022 recommend universal screening for GDM between 24-28 weeks of gestation with a 75 g OGTT [10].", "nodes": ["condition:gdm", "test:ogtt", "guideline_org:ada", "guideline_org:nice", "threshold_or_timing:24-28 weeks"], "edge_types": ["SCREEN_24_28_WEEKS"], "edge_evidence": {"SCREEN_24_28_WEEKS": 3}, "confidence": 0.76}
{"id": "c0000299", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomia should undergo screening earlier than 15 weeks of gestation to detect potential glucose intolerance before it worsens [11].", "nodes": ["condition:gdm", "outcome_fetal:macrosomia", "risk_factor:bmi", "risk_factor:family history", "threshold_or_timing:15 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.4}
{"id": "c0000300", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "nodes": ["test:ogtt", "guideline_org:ada", "threshold_or_timing:92 mg/dL", "threshold_or_timing:5.1 mmol/L", "threshold_or_timing:180 mg/dL", "threshold_or_timing:153 mg/dL", "threshold_or_timing:8.5 mmol/L"], "edge_types": ["THRESHOLD_CRITERIA", "MONITORING_TARGETS"], "edge_evidence": {"THRESHOLD_CRITERIA": 3, "MONITORING_TARGETS": 2}, "confidence": 1.0}
{"id": "c0000301", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Moreover, WHO’s diagnostic thresholds include fasting glucose ≥92 mg/dL and a two-hour ≥153 mg/dL [11].", "nodes": ["guideline_org:who", "threshold_or_timing:92 mg/dL", "threshold_or_timing:153 mg/dL"], "edge_types": ["THRESHOLD_CRITERIA", "MONITORING_TARGETS"], "edge_evidence": {"THRESHOLD_CRITERIA": 3, "MONITORING_TARGETS": 2}, "confidence": 0.98}
{"id": "c0000302", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Rising GDM incidence correlates with increasing maternal age and obesity.", "nodes": ["condition:gdm", "condition:obesity", "risk_factor:maternal age", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000303", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Discrepancies in criteria (e.g., IADPSG vs.", "nodes": ["guideline_org:iadpsg"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000304", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Despite these minor variations in the diagnostic criteria, early detection and intervention have been agreed upon by both societies as the most crucial factor in the management of GDM [12].", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000305", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Early detection of the condition allows timely treatment to be instituted that can diminish the risks of maternal complications such as preeclampsia, cesarean delivery, and worsening of pre-existing diabetes, and fetal complications such as macrosomia, birth defects, and neonatal hypoglycemia [10].", "nodes": ["tissue:liver", "condition:hypoglycemia", "condition:preeclampsia", "outcome_maternal:preeclampsia", "outcome_maternal:cesarean", "outcome_fetal:macrosomia", "outcome_fetal:neonatal hypoglycemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.36}
{"id": "c0000306", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Further, it is also emphasized in some recommendations that children born to women with GDM have long-term risks of obesity and later development of T2DM, thus requiring follow-up care for many years after delivery [13].", "nodes": ["tissue:liver", "condition:t2dm", "condition:gdm", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000307", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Moreover, children born to women with GDM can inherit type 1 diabetes despite glycemic control [14].", "nodes": ["condition:gdm", "condition:type 1 diabetes"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000308", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Management of pre-existing diabetes Pre-existing diabetes control consists of optimizing HbA1c before conception, throughout pregnancy, and after delivery in order to prevent congenital malformations and stillbirth as well as for screening complications and education on hypoglycemia.", "nodes": ["tissue:liver", "condition:hypoglycemia", "test:hba1c", "outcome_fetal:stillbirth", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000309", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Strict glycemic control is especially important to improve pregnancy outcomes and decrease maternal and fetal complications since uncontrolled blood glucose is dangerous in terms of causing maternal and fetal adverse outcomes such as preeclampsia, macrosomia, and birth defects [15].", "nodes": ["condition:preeclampsia", "outcome_maternal:preeclampsia", "outcome_fetal:macrosomia"], "edge_types": ["IMPROVES_OUTCOMES"], "edge_evidence": {"IMPROVES_OUTCOMES": 3}, "confidence": 0.6}
{"id": "c0000310", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The ADA (2023) also recommended folic acid supplementation to reduce the risk of neural tube defects, and tests for cardiovascular health, renal function, and diabetic complication screening like retinopathy, nephropathy, and neuropathy [16].", "nodes": ["guideline_org:ada"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000311", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (7.8 mmol/L) one hour after meals [17].", "nodes": ["guideline_org:ada", "guideline_org:nice", "threshold_or_timing:95 mg/dL", "threshold_or_timing:5.3 mmol/L", "threshold_or_timing:140 mg/dL", "threshold_or_timing:7.8 mmol/L"], "edge_types": ["MONITORING_TARGETS"], "edge_evidence": {"MONITORING_TARGETS": 3}, "confidence": 0.79}
{"id": "c0000312", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It must be noted that early pregnancy hyperglycemia is associated with an increased risk of congenital malformations, while hyperglycemia later in pregnancy results in fetal overgrowth (macrosomia) and other complications such as shoulder dystocia during delivery [18].", "nodes": ["tissue:liver", "condition:hyperglycemia", "outcome_fetal:shoulder dystocia", "outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000313", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Insulin treatment remains the mainstay of treatment in most women with established diabetes.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000314", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Whereas oral medications like metformin and glyburide are potentially available to use, the drugs are infrequently utilized in pregnancy, specifically pre-gestational status, due to potential issues of safety and fetal welfare, especially in the first trimester.", "nodes": ["intervention:metformin", "intervention:glyburide", "drug:metformin", "drug:glyburide"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000315", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Basal-bolus insulin therapy can be included and adjusted to fit the patient, whose needs might vary during the pregnancy as with increased insulin resistance.", "nodes": ["condition:insulin resistance", "guideline_org:who", "intervention:insulin", "drug:insulin"], "edge_types": ["TREATED_BY"], "edge_evidence": {"TREATED_BY": 3}, "confidence": 0.63}
{"id": "c0000316", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The management plan must be comprehensive, for example, regular blood glucose monitoring (self-monitoring of blood glucose (SMBG)) to guide insulin adjustments to maintain the target range of glucose [9].", "nodes": ["test:smbg", "intervention:insulin", "drug:insulin", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000317", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Continuous Glucose Monitoring (CGM) CGM is becoming increasingly popular in diabetes management in pregnancy because it can potentially provide real-time data and prevent hyperglycemia and hypoglycemia.", "nodes": ["condition:hypoglycemia", "condition:hyperglycemia", "test:continuous glucose monitoring", "test:cgm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000318", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "CGM decreases hypoglycemia and HbA1c by 0.5% compared to SMBG [19].", "nodes": ["condition:hypoglycemia", "test:hba1c", "test:smbg", "test:cgm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000319", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "CGM is not without issues, including barriers to use, with about 40% of the patients being non-adherent, concerns about fear of hypoglycemia, and expense, with the cost being about $300 per month for the uninsured.", "nodes": ["condition:hypoglycemia", "test:cgm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000320", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Such patients require frequent antenatal follow-ups for medication dose adjustment, checking of maternal health, and evaluation of fetal growth, preferably with ultrasound for checking for signs of macrosomia or other pathology.", "nodes": ["outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000321", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Regular screening should also be performed for complications like preeclampsia, diabetic ketoacidosis, or urinary tract infection so that early intervention may be done.", "nodes": ["condition:preeclampsia", "outcome_maternal:preeclampsia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000322", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Multidisciplinary teamwork needs to be given due attention by obstetricians, endocrinologists, dietitians, and other healthcare providers in order to take care of and deal with the complex needs of pregnant women with pre-existing diabetes [9].", "nodes": ["intervention:diet"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000323", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Insulin Pump Therapy An RCT in 2017 established that insulin pumps improve glycemic control in pregnant women with type 1 diabetes.", "nodes": ["condition:type 1 diabetes", "intervention:insulin", "drug:insulin"], "edge_types": ["TREATED_BY"], "edge_evidence": {"TREATED_BY": 3}, "confidence": 0.6}
{"id": "c0000324", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It showed that women receiving insulin pumps had much better HbA1c levels, fewer severe hypoglycemic events by 35%, and fewer rates of neonatal hypoglycemia compared to women receiving insulin injections [20].", "nodes": ["condition:hypoglycemia", "test:hba1c", "intervention:insulin", "drug:insulin", "outcome_fetal:neonatal hypoglycemia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.3}
{"id": "c0000325", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Moreover, fewer neonatal intensive care unit (NICU) admissions were experienced.", "nodes": ["outcome_fetal:nicu"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000326", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "These studies affirm the benefits of insulin pumps in achieving optimal glucose control and reducing undesirable outcomes.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000327", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Insulin pumps, although beneficial, require careful monitoring and pose some drawbacks, including a risk of infection due to inadequate site rotation and limited access or coverage, particularly in low-resource settings where cost is likely to be a significant barrier [21].", "nodes": ["intervention:insulin", "drug:insulin", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000328", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Pregnant women on insulin pumps should have good hygiene practices, such as frequent site rotation of the infusion, to minimize such risks.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000329", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Additionally, technical problems in insulin pumps, such as malfunction or failure of the pump, can cause interruptions in insulin infusion.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000330", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "If the pump fails, the patient will be required to have a backup, normally reverting to a subcutaneous infusion of insulin.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000331", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The cost of insulin pumps may also be a major constraint in areas where insurance does not cover the pump or the supplies for it.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000332", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Accessibility of insulin pumps is also restricted in some countries and healthcare systems; thus, not all pregnant women with diabetes will be able to use them.", "nodes": ["intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000333", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Monitoring of Complications Besides optimization of insulin delivery, pregnant women with existing diabetes need close monitoring of complications such as hypertensive disorders, diabetic ketoacidosis (DKA), and fetal growth anomalies that can threaten the life of both mother and baby [22].", "nodes": ["tissue:liver", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000334", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The mother's hyperglycemic state causes fetal abnormalities of pregnancy; glucose is transferred from the mother to the fetus through the placenta, resulting in macrosomia, intrauterine growth restriction, congenital anomalies, preterm birth, and neonatal hypoglycemia in the newly born infants [23].", "nodes": ["tissue:placenta", "tissue:fetus", "condition:hypoglycemia", "outcome_fetal:preterm birth", "outcome_fetal:macrosomia", "outcome_fetal:neonatal hypoglycemia"], "edge_types": ["CROSSES_PLACENTA"], "edge_evidence": {"CROSSES_PLACENTA": 2}, "confidence": 0.61}
{"id": "c0000335", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The severity of such complications has a close relation to the control of maternal glycemia, with the highest risk to both mother and fetus if diabetes is inadequately controlled.", "nodes": ["tissue:fetus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000336", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Furthermore, maternal complications of preeclampsia, cesarean section, and worsening of underlying diabetes can complicate the pregnancy [24].", "nodes": ["condition:preeclampsia", "outcome_maternal:preeclampsia", "outcome_maternal:cesarean"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000337", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Fetal complications Diabetic gestation sequelae in the fetus are many and may have severe effects on the baby's short- and long-term health.", "nodes": ["tissue:fetus"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000338", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "One of the most common and severe short-term sequelae is macrosomia, birth weight greater than 4000-4500 grams, with a 26% incidence rate [25].", "nodes": ["outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000339", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It occurs as a result of hyperglycemia in the maternal circulation, which crosses the placenta and leads to fetal hyperinsulinemia.", "nodes": ["tissue:placenta", "condition:hyperglycemia", "intervention:insulin", "drug:insulin"], "edge_types": ["STIMULATES_INSULIN"], "edge_evidence": {"STIMULATES_INSULIN": 3}, "confidence": 0.63}
{"id": "c0000340", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Because of this, the fetus is overgrown and may suffer several birth injuries, such as shoulder dystocia (3-12% rate of incidence), brachial plexus injury, and fractures of the clavicle [26].", "nodes": ["tissue:fetus", "outcome_fetal:shoulder dystocia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000341", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Furthermore, macrosomic neonates are prone to neonatal hypoglycemia (25% incidence rate) since the intrauterine hyperglycemic environment leads their pancreas to continue releasing excess insulin, and their blood glucose can fall sharply once glucose transfer from the placenta is stopped after birth.", "nodes": ["tissue:placenta", "tissue:pancreas", "condition:hypoglycemia", "intervention:insulin", "drug:insulin", "outcome_fetal:neonatal hypoglycemia"], "edge_types": ["CROSSES_PLACENTA"], "edge_evidence": {"CROSSES_PLACENTA": 2}, "confidence": 0.61}
{"id": "c0000342", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In the long term, in-utero exposure to high blood glucose levels is linked to a 1.5-fold higher risk of obesity in children and a 7.4-fold higher risk of T2DM [27,28].", "nodes": ["condition:t2dm", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000343", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "A few congenital anomalies seen in pregnancies complicated by maternal hyperglycemia are cardiac malformations like ventricular septal defects, neural tube defects like spina bifida, renal malformations like renal agenesis, and osseous dysplasias like caudal regression syndrome.", "nodes": ["condition:hyperglycemia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000344", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In addition, both pre-existing diabetes and GDM have been associated with an increased risk of stillbirth, particularly with poor control of maternal blood glucose.", "nodes": ["condition:gdm", "outcome_fetal:stillbirth"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000345", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Hyperglycemia also causes placental insufficiency, which damages the blood and oxygen supply to the fetus and generates increased risks of fetal mortality.", "nodes": ["tissue:placenta", "tissue:fetus", "condition:hyperglycemia", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000346", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Studies show that tight regulation of blood glucose in pregnancy can reduce the risk of stillbirth [31].", "nodes": ["outcome_fetal:stillbirth"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000347", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "This risk does not diminish once gross birth defects and complications in children of diabetic women, poorly controlled in this case, have been avoided; children are at lifetime risk for disease, including obesity as a child and T2DM.", "nodes": ["condition:t2dm", "condition:obesity"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000348", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It has been suggested that the following heightened risk is due to the intrauterine environment, with fetal overinsulin production and abnormal growth patterns setting the stage for later metabolic malfunction [32].", "nodes": ["intervention:insulin", "drug:insulin", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000349", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Thus, good diabetic control during pregnancy is not only required to reduce the short-term risks of delivery but also to reduce the subsequent chronic disease burden in the infant.", "nodes": ["tissue:liver"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000350", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Management of GDM GDM normally reverses after the gestational period.", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000351", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "However, the disease dramatically increases the chance of T2DM in the later years.", "nodes": ["condition:t2dm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000352", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Main management priorities in GDM involve attempts toward achieving normoglycemia to prevent complications for the mother and the fetus.", "nodes": ["tissue:fetus", "condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.24}
{"id": "c0000353", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The first line of managing GDM involves changes in lifestyle such as nutrition, in addition to physical activities if allowed by the gynecologist.", "nodes": ["condition:gdm", "intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000354", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrate counting to help prevent hyperglycemia, as stated by ADA (2023), and NICE (2022), and regular physical activities such as brisk walking for 150 minutes per week if recommended by the gynecologist to improve insulin sensitivity [33].", "nodes": ["condition:hyperglycemia", "guideline_org:ada", "guideline_org:nice", "intervention:insulin", "intervention:diet", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000355", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "However, in some women, lifestyle interventions by themselves often are inadequate for optimum glycemic control.", "nodes": ["intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000356", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In cases when glycemic targets cannot be achieved through diet and exercise, pharmacologic therapy is instituted.", "nodes": ["intervention:diet", "intervention:exercise"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000357", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Insulin, whether neutral protamine hagedorn (NPH) or analogs, remains the first-line treatment, as it does not cross the placenta and has a long-established safety record [9].", "nodes": ["tissue:placenta", "intervention:insulin", "drug:insulin", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000358", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Oral medications, such as metformin and glyburide, may be considered if insulin is refused.", "nodes": ["intervention:insulin", "intervention:metformin", "intervention:glyburide", "drug:metformin", "drug:insulin", "drug:glyburide"], "edge_types": [], "edge_evidence": {}, "confidence": 0.33}
{"id": "c0000359", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "However, it has been associated with preterm birth [34].", "nodes": ["outcome_fetal:preterm birth"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000360", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "The ADA (2023) recommends starting insulin therapy when fasting blood glucose is above 95 mg/dL (5.3 mmol/L) or when postprandial glucose levels are above 140 mg/dL (7.8 mmol/L) [8].", "nodes": ["guideline_org:ada", "intervention:insulin", "drug:insulin", "threshold_or_timing:95 mg/dL", "threshold_or_timing:5.3 mmol/L", "threshold_or_timing:140 mg/dL", "threshold_or_timing:7.8 mmol/L"], "edge_types": ["MONITORING_TARGETS"], "edge_evidence": {"MONITORING_TARGETS": 2}, "confidence": 0.74}
{"id": "c0000361", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "This requires close monitoring of blood glucose to adjust insulin dosing and avoid hypoglycemia and hyperglycemia.", "nodes": ["condition:hypoglycemia", "condition:hyperglycemia", "intervention:insulin", "drug:insulin"], "edge_types": [], "edge_evidence": {}, "confidence": 0.27}
{"id": "c0000362", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Besides careful maternal blood glucose management, the fetus must also be followed closely.", "nodes": ["tissue:fetus", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000363", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Regular SMBG is recommended to ensure that maternal glucose levels stay within target ranges.", "nodes": ["test:smbg"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000364", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Fetal surveillance, including routine ultrasounds every four weeks and a fetal echocardiogram if first-trimester hyperglycemia was present, is particularly important in cases of poor glycemic control or suspected macrosomia, as these conditions increase the risk of complications [35].", "nodes": ["condition:hyperglycemia", "outcome_fetal:macrosomia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000365", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Given that macrosomic newborns are more likely to suffer birth complications such as shoulder dystocia, time of delivery is crucial.", "nodes": ["tissue:liver", "outcome_fetal:shoulder dystocia"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000366", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with poor control need to be delivered at 37-38 weeks, though the timing may vary based on individual factors, including glycemic control and fetal growth [36].", "nodes": ["tissue:liver", "condition:gdm", "guideline_org:who", "intervention:diet", "threshold_or_timing:39-40 weeks", "threshold_or_timing:37-38 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.43}
{"id": "c0000367", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Postpartum care GDM women should have close follow-up management for the development of chronic diabetes.", "nodes": ["condition:gdm", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000368", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "nodes": ["tissue:liver", "condition:t2dm", "test:ogtt", "guideline_org:ada", "threshold_or_timing:4-12 weeks"], "edge_types": [], "edge_evidence": {}, "confidence": 0.4}
{"id": "c0000369", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In addition, breastfeeding has been found to reduce maternal T2DM risk by 32%.", "nodes": ["condition:t2dm"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000370", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Lifestyle modification education for the reduction of T2DM is also a part of postpartum care [38].", "nodes": ["condition:t2dm", "intervention:lifestyle"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000371", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Conclusions The clinical guidelines on the management of diabetes play a crucial role in optimizing maternal and fetal outcomes by providing evidence-based recommendations.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000372", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "In addition, the recommendation for all insurance providers to cover continuous glucose monitoring and checkups prior to conception may ensure equity of access to preventing diabetes and best management.", "nodes": ["test:continuous glucose monitoring", "risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.21}
{"id": "c0000373", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "It thus behooves sustained efforts to improve the response to diabetes management and support pregnant women with diabetes as one way of ensuring better maternal and child health in developing countries.", "nodes": ["risk_factor:age"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000374", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Disclosures Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.", "nodes": ["risk_factor:bmi"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000375", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.", "nodes": ["risk_factor:bmi"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}
{"id": "c0000376", "doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "text": "Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.", "nodes": ["risk_factor:bmi"], "edge_types": [], "edge_evidence": {}, "confidence": 0.18}